PGNY

Progyny, Inc. Common Stock

29.19

USD

+0.79

+2.78%

Oct 30, 16:00 UTC -4

Closed

After-Market

29.05

-0.14

-0.50%

Progyny, Inc. Common Stock (PGNY) Earnings

PGNY Earnings Reports

Positive Surprise Ratio

PGNY beat 20 of 28 last estimates.

71%

Next Report

Next Week

Date of Next Report

Nov 04, 2026

Estimate for Q3 26 (Revenue/ EPS)

$347.74M

$0.31

Implied change from Q2 26 (Revenue/ EPS)

-0.79%

-8.82%

Implied change from Q3 25 (Revenue/ EPS)

+10.98%

+106.67%

Progyny, Inc. Common Stock earnings per share and revenue

On Aug 06, 2026, PGNY reported earnings of 0.34 USD per share (EPS) for Q2 26, missing the estimate of 0.34 USD, resulting in a -0.50% surprise. Revenue reached 350.51 million, compared to an expected 355.66 million, with a -1.45% difference. The market reacted with a -6.98% price change (close before vs. close after earnings).

Looking ahead to Q3 26, -- analysts forecast an EPS of 0.31 USD, with revenue projected to reach 347.74 million USD, implying an decrease of -8.82% EPS, and decrease of -0.79% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Bausch + Lomb Corporation

Report Date

Oct 28, 2026 For Q3 26

Estimate

$0.22

Actual

$0.34

Surprise

+53.43%

CareDx, Inc.

Report Date

Oct 29, 2026 For Q3 26

Estimate

$0.25

Actual

$0.70

Surprise

+178.44%

Pediatrix Medical Group, Inc.

Report Date

Oct 29, 2026 For Q3 26

Estimate

$0.66

Actual

$0.72

Surprise

+7.61%

Establishment Labs Holdings Inc.

Report Date

Oct 29, 2026 For Q3 26

Estimate

-$0.26

Actual

-$0.35

Surprise

-33.69%

HCA Healthcare, Inc.

Report Date

Oct 27, 2026 For Q3 26

Estimate

$6.72

Actual

$7.22

Surprise

+7.29%

Labcorp Holdings Inc.

Report Date

Oct 28, 2026 For Q3 26

Estimate

$4.79

Actual

$4.78

Surprise

-0.31%

Icon Plc

Report Date

Oct 27, 2026 For Q3 26

Estimate

$2.65

Actual

$2.66

Surprise

+0.27%

BrightSpring Health Services, Inc. Common Stock

Report Date

Oct 30, 2026 For Q3 26

Estimate

$0.48

Actual

$0.54

Surprise

+12.20%

Avantor, Inc.

Report Date

Oct 28, 2026 For Q3 26

Estimate

$0.21

Actual

$0.22

Surprise

+3.92%

Alignment Healthcare, Inc. Common Stock

Report Date

Oct 29, 2026 For Q3 26

Estimate

-$0.03

Actual

-$0.04

Surprise

-13.96%

FAQ

What were Progyny, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Progyny, Inc. Common Stock reported EPS of $0.34, missing estimates by -0.5%, and revenue of $350.51M, -1.45% below expectations.

How did the market react to Progyny, Inc. Common Stock's Q2 2026 earnings?

The stock price moved down -6.98%, changed from $30.21 before the earnings release to $28.10 the day after.

When is Progyny, Inc. Common Stock expected to report next?

The next earning report is scheduled for Nov 04, 2026.

What are the forecasts for Progyny, Inc. Common Stock's next earnings report?

Based on -- analysts, Progyny, Inc. Common Stock is expected to report EPS of $0.31 and revenue of $347.74M for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.